Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Daily News

Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests

Todd Neale

July 28, 2016

News Daily News

Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib

Todd Neale

June 09, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2016

Shelley Wood

April 29, 2016

News Daily News

Final CMS Decision Memo for Watchman Dumps Controversial Warfarin Contraindication

Shelley Wood

February 08, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

News Daily News

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

L.A. McKeown

December 10, 2015

News Daily News

Does the Watchman LAA Occluder Reduce Bleeding?

L.A. McKeown

November 25, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Conference News TCT 2015

Use of LAA Occlusion in Low-Risk Patients Debated

Todd Neale

October 11, 2015

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

Presentation TCT 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presenter: Vivian Lee

September 16, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Advertisement

Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests

Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib

TCTMD’s Top 10 Most Popular Stories for April 2016

Final CMS Decision Memo for Watchman Dumps Controversial Warfarin Contraindication

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

Does the Watchman LAA Occluder Reduce Bleeding?

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

Use of LAA Occlusion in Low-Risk Patients Debated

Statement on LAA Closure Highlights Key Issues for Growing Field

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Registry Data Suggest Protection Up to 2 Years With LAA Closure

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content